Ticker Hub
GOVX — AI Analysis & Sentiment
4 recent AI-generated analyses for GOVX. Sentiment and confidence insights updated continuously.
GeoVax Reports 2025 Year-End Financial Results and Provides Business Update
GeoVax's 2025 financial report reveals a severely depleted cash position and significant operating losses, pointing to an urgent need for capital a...
Apr 15, 2026GeoVax Provides Update on GEO-MVA Program
GeoVax has completed a key manufacturing milestone for its GEO-MVA vaccine, with final product release expected in early April. This significantly ...
Mar 25, 2026GeoVax Announces European Society of Medicine Publication Highlighting GEO-CM04S1 as a Next-Generation COVID-19 Vaccine for Immunocompromised Patients
Peer-reviewed publication of GEO-CM04S1 data provides scientific validation for GeoVax's COVID-19 vaccine targeting immunocompromised patients. Thi...
Mar 12, 2026GeoVax Initiates Outreach Regarding Future Procurement of GEO-MVA Mpox/Smallpox Vaccine
GeoVax's outreach for future GEO-MVA procurement and expedited EMA pathway marks a significant move towards commercialization. This development for...
Mar 11, 2026